Pioglitazone enhances insulin sensitivity in patients with Type 2 diabetes mellitus.

被引：0
|
作者：
Pavo, I
Herz, M
Tan, M
Shestakova, MV
Smirnova, OM
Jermendy, G
Kerenyi, Z
Widel, MH
Schluchter, BJ
Johns, D
机构：
[1] Lilly Res Labs, Area Med Ctr Vienna, Vienna, Austria
[2] Eli Lilly & Co, Indianapolis, IN USA
[3] Endocrinol Res Ctr, Moscow, Russia
[4] Bajesy Zsilinszky Hosp, Budapest, Hungary
[5] St Imre Hosp, Budapest, Hungary
来源：
DIABETOLOGIA | 2002年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
779
引用
收藏
页码：A250 / A250
页数：1
相关论文
共 50 条
  • [31] Comparison of insulin sensitivity in patients with insulinoma and obese type 2 diabetes mellitus
    Skrha, J
    Sindelka, G
    Haas, T
    Hilgertova, J
    Justova, V
    HORMONE AND METABOLIC RESEARCH, 1996, 28 (11) : 595 - 598
  • [32] Update in the treatment of type 2 diabetes mellitus.: The spring of insulin-sensitizers.
    Brogard, JM
    Neyrolles, N
    Andres, E
    Blicklé, JF
    REVUE DE MEDECINE INTERNE, 1999, 20 : 371S - 378S
  • [33] Mycotic complications in patients with insulin dependent diabetes mellitus.
    Sokolova, G
    Silnizkiy, P
    Mirsabalaeva, A
    Vorokhobina, N
    Volkova, E
    DIABETOLOGIA, 1997, 40 : 2353 - 2353
  • [34] Update in the treatment of type 2 diabetes mellitus.: Insulin secreting agents.
    Blicklé, JF
    Andres, E
    Neyrolles, N
    Brogard, JM
    REVUE DE MEDECINE INTERNE, 1999, 20 : 351S - 359S
  • [35] Combination therapy with pioglitazone and insulin in patients with type 2 diabetes
    Rubin, C
    Egan, J
    Schneider, R
    DIABETES, 1999, 48 : A110 - A110
  • [36] An assessment of all-cause mortality for pioglitazone compared with insulin in patients with type 2 diabetes mellitus
    Yu, S.
    Yang, J.
    Bron, M.
    Perez, A.
    Vallarino, C.
    Fusco, G.
    Liang, H.
    Harikrishnan, V.
    Joseph, G.
    DIABETOLOGIA, 2012, 55 : S499 - S499
  • [37] Effect of glycine on insulin secretion, fasting and postprandial glucose levels in patients with Type 2 diabetes mellitus.
    Martínez-Abundis, E
    Kam-Ramos, AM
    Hernández-Salazar, E
    González-Ortiz, M
    DIABETOLOGIA, 2003, 46 : A261 - A262
  • [38] Pioglitazone: A review of its use in type 2 diabetes mellitus. (vol 66, pg 86, 2006)
    Waugh, J
    Keating, GM
    Plosker, GL
    Easthope, S
    Robinson, DM
    DRUGS, 2006, 66 (03) : 340 - 341
  • [39] Pioglitazone in the Treatment of Diabetes Mellitus Type 2
    Zach, Herwig
    JOURNAL FUR HYPERTONIE, 2011, 15 (04): : 58 - 58
  • [40] Hepatic steatosis and type 2 diabetes mellitus.
    Clark J.M.
    Diehl A.M.
    Current Diabetes Reports, 2002, 2 (3) : 210 - 215
12345